Real-Time PCR Test Identifies Aspergillus

Diagnosis of Aspergillus infection followed by antifungal treatment within the first 10 days of infection reduces mortality from 90% to 40% highlighting the necessity of early, rapid diagnostic testing.

Myconostica (London, UK), a medical diagnostic company specializing in rapid molecular diagnostic tests for life-threatening fungal infections, launched the MycAssay Aspergillus test, which has gained CE marking.

Traditional methods used to identify Aspergillus infections are inaccurate, insensitive, and slow, with a result taking up to 10 days to obtain. When MycAssay Aspergillus is combined with Myconostica´s fungal DNA extraction system, MycXtra, a result can be obtained within 3 hours. This provides a rapid, sensitive, and specific alternative to the conventional techniques used to identify Aspergillus infections.

Related Links:
Myconostica